350
Participants
Start Date
March 9, 2017
Primary Completion Date
September 6, 2018
Study Completion Date
March 1, 2019
Routine care
This study is an observational one - there is no change to the routine care. Patients received the Nivolumab independently of the study. Only data will be collected during this project.
Hôpitaux de Marseille, Marseille
Chu Dijon, Dijon
Ch Valence, Valence
Chu Toulouse, Toulouse
Hopital St andré-CHU DE Bordeaux, Bordeaux
CHU de Grenoble, Grenoble
Chru Lille, Lille
Chu Clermont-Ferrand, Clermont-Ferrand
CH de PAU, Pau
Centre Léon Bérard de Lyon, Lyon
Hospices Civils de Lyon: Lyon Sud, Lyon
CH du Mans, Le Mans
CHU de Rouen, Rouen
Chu Amiens, Amiens
Institut Gustave Roussy, Villejuif
AP-HP Hôpital Ambroise Paré, Paris
CHU NICE, Nice
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Nantes University Hospital
OTHER